Free Trial

10 Best Small Cap Stocks to Buy Now - 8 of 10

 
 

MiMedx Group (NASDAQ:MDXG)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$12.00 (29.3% Upside)

About MiMedx Group

MiMedx Group logoMiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
8/1/2024Craig HallumLower Price TargetBuy ➝ Buy$14.00 ➝ $12.00
8/1/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$11.00 ➝ $11.00
7/2/2024Cantor FitzgeraldInitiated CoverageOverweight$11.00
5/1/2024HC WainwrightReiterated RatingBuy ➝ Buy$11.00
3/7/2024Lake Street CapitalInitiated CoverageBuy$12.00
3/1/2024MizuhoBoost Price TargetBuy ➝ Buy$13.00 ➝ $14.00
10/31/2023MizuhoLower Price TargetBuy ➝ Buy$14.00 ➝ $12.00
10/27/2023Craig HallumInitiated CoverageBuy$12.00
8/9/2023MizuhoBoost Price Target$12.00 ➝ $14.00
8/2/2023MizuhoBoost Price TargetBuy ➝ Buy$10.00 ➝ $12.00
 

I was wrong. Dead wrong. (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.